SkinBioTherapeutics Loss Widens As It Targets Commercialisation
LONDON (Alliance News) - SkinBioTherapeutics PLC on Thursday reported a widened interim loss on the back of higher research costs as it looks to advance the commercialisation of its main the six a Read More